TipRanks
Go Ultimate55% OFF

Robert Forrester Insider Profile

4 Followers

Robert Forrester, President & CEO, Director at Verastem, holds 231.23K shares in Verastem (Ticker: VSTM), holds ― shares in Immunomedics (Ticker: IMMU), holds 24.38K shares in Epirus Biopharma (Ticker: EPRSQ). Most recently, Robert Forrester Bought ― shares of Verastem on Oct 02, 2018 for an estimated value of $14.00K.

Robert Forrester's Trading History

VSTM
Verastem
Oct 02, 2018President & CEO, DirectorInformative Buy14.00K$2.25M
EPRSQ
Epirus Biopharma
Jan 28, 2009―Uninformative Sell1.66K$12.19K
IMMU
Immunomedics
――――

You May Also Like

Robert Forrester insider profile FAQ

What is the percentage of profitable transactions made by Robert Forrester?
The percentage of profitable transactions made by Robert Forrester is 17%.
What is the average return per transaction made by Robert Forrester?
The average return per transaction made by Robert Forrester is -66.60%.
What stocks does Robert Forrester hold?
Robert Forrester holds: VSTM, IMMU, EPRSQ stocks.
What was Robert Forrester’s latest transaction?
Robert Forrester’s latest transaction was an Informative Buy of $14.00K.
What was Robert Forrester's most profitable transaction?
Robert Forrester’s most profitable transaction was an Informative Buy of VSTM stock on May 13, 2014. The return on the trade was 9.80%.
What is Robert Forrester's role in Verastem?
Robert Forrester's role in Verastem is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.